Back to results
US 2003/0194377 A1Published application
Therapeutic uses of BPI protein products in cystic fibrosis patients
OwnerStephen Fitzhugh Carroll, Patrick J. Scannon +1inventors
InventorsStephen Fitzhugh Carroll, Patrick J. Scannon, Patrick D. Gavit
Life of this patent
Estimating the term…
Abstract
Improved therapeutic uses and formulations for BPI protein products are described in cystic fibrosis patients.
Claims22
In a method of treating a cystic fibrosis patient with a bactericidal/permeability-increasing (BPI) protein product, the improvement comprising administering an N-terminal BPI protein product to a subject having non-N-terminal-BPI-reactive antibodies.
A composition for aerosol delivery comprising a BPI protein product and a poloxamer surfactant at a concentration of 0.3% or more.
Dependencies are inferred from the claim text.